Toronto extremity salvage score-patient reported outcome measures in upper extremity bone tumors treated with limb salvage surgery


  • Subbiah Shanmugam Department of Surgical Oncology, Govt Royapettah Hospital, Chennai, Tamil Nadu, India
  • Sandhya P. A. Department of Surgical Oncology, Govt Royapettah Hospital, Chennai, Tamil Nadu, India



TESS score, Patient reported outcome measures, MSTS score, Bone tumours of upper limb


Bone and soft tissue tumors of upper extremity are relatively uncommon than those of lower limb. Treating these patients while retaining a functional limb is quite a challenge. Along with musculoskeletal tumor society score, Toronto extremity salvage score (TESS) is most widely used patient-reported outcome measure for sarcomas of upper extremity. Retrospective analysis of patients with upper extremity bone tumors (24) treated with limb salvage surgery (20) from 2014 to 2022 was undertaken.  Mean follow-up period was 26 months and mean age was 30.2 years. Out of 20, 11 humerus cases were of tumors arising from humerus, 5 in radius and 3 in ulna. 9 patients were treated with custom mega prosthesis reconstruction, 6 with fibular free flap, 6 radius underwent simple resection and 1 curettage. Majority of the cases were giant cell tumors (8) followed by osteosarcoma (3), fibromatosis (3), aneurysmal bone cyst (2), simple bone cyst (2), 1 Ewing sarcoma and 1 metastatic bone disease. The mean TESS score of the sample population was 69.7 Most of the patients (11) rated their disability to be of moderate degree and considered themselves to be moderately disabled. The mean TESS score for CMP group was 71.1, while that of autograft reconstruction was 68.3. Despite only half the population having received CMP as a reconstructive option, nearly 40% patients with disease of forearm where the results are not so great, our study population reported a reasonably good patient reported outcome score. A dedicated physiotherapy team with tailor made exercise protocol for each patient depending on their needs can help in improving the quality of life.


Wright EH, Gwilym S, Gibbons CL, Critchley P, Giele HP. Functional and oncological outcomes after limb-salvage surgery for primary sarcomas of the upper limb. J Plast Reconstr Aesthet Surg. 2008;61(4):382-7.

Qadir I, Umer M, Baloch N. Functional outcome of limb salvage surgery with mega-endoprosthetic reconstruction for bone tumors. Arch Orthop Trauma Surg. 2012;132(9):1227-32.

Malek F, Somerson JS, Mitchel S, Williams RP. Does limb-salvage surgery offer patients better quality of life and functional capacity than amputation? Clin Orthop Relat Res. 2012;470(7):2000-6.

Janssen SJ, Van Rein EAJ, Pereira NRP, Raskin KA, Ferrone ML, Hornicek FJ et al. The Discrepancy between Patient and Clinician Reported Function in Extremity Bone Metastases. Sarcoma. 2016;1014248:6.

Shanmugam S, Susikar S, Bharanidharan T, Victor A, Shanmugam SJ. Demographic, Clinico-pathological features and management pattern of primary bone tumors in a tertiary care hospital of South India. Int J Res Orthop. 2022;8(1):60-63

Ketola H, Kask G, Barner-Rasmussen I, Tukiainen E, Blomqvist C, Laitinen MK et al. Measuring functional outcome in upper extremity soft-tissue sarcoma: Validation of the Toronto extremity salvage score and the Quick DASH patient-reported outcome instruments. J Plast Reconstr Aesthet Surg. 2022;75(5):1543-50.

Bergovec M, Kubat O, Smerdelj M, Seiwerth S, Bonevski A, Orlic D. Epidemiology of musculoskeletal tumors in a national referral orthopedic department. A study of 3482 cases. Cancer Epidemiol. 2015;39(3):298-302.

Ellerbrock M, Theil C, Gosheger G. Function and return to sports after proximal humeral replacement in patients with primary bone sarcoma. J Orthop Traumatol. 2022;23:59.

Maurizio S, Matthew HT, Courtney SE, Franklin SH, O'Connor MI. Survival, Tumor Recurrence, and Function Following Shoulder Girdle Limb Salvage at 24 to 35 Years of Follow-up. Orthopedics. 2019;42(6):e514-20.